Vendor source
Reviewed 2 Jun 2026
Completeness Good (53%)
Aiforia® Breast Cancer Grading
Aiforia Technologies PlcAiforia® Breast Cancer Grading automates breast cancer grading from H&E-stained whole slide images (WSI), identifying invasive carcinoma and ductal carcinoma in situ (DCIS). It scores mitotic count, tubular formation, and nuclear pleomorphism in line with the Nottingham Grading System. The aim of the software is to reduce variability and save time.
No papers to support — we monitor for new evidence.
General Information
Product name
Company
Modality
Main task
Subspeciality
Organ/Specimen source
Not specified
Disease targeted
Specimen type
Not specified
Staining
Stain subtype
Not specified
Regulatory Information
Pathway:
In Vitro Diagnostic Regulation (IVDR)
Class:
Class C
Verified by Health AI Register
Scanner Brands Certified for Use (CE-IVD)
Not specified
Scanner Models Certified for Use (CE-IVD)
Not specified
Other certifications
Not specified
Evidence & Research
No research papers or evidence on file yet.
The registry monitors publications for new evidence.
Technical Specifications
Patient population age
Not specified
Input
Input format
Not specified
Output
Output format
Not specified
Integration
Deployment
Trigger for analysis
Processing time
Not specified
Population
Viewer systems
Market Presence
On market since
AI Platforms
Resellers
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Not specified
Based on
Not specified
Source: Vendor | First published: Jul 30, 2025 | Last updated: Jun 2, 2026